Moreover, key molecules involved in CRC development, such as Wnt, KRAS, and p53, also function as metabolic regulators, suggesting that alterations in these pathways can significantly influence CRC initiation, progression, and metastasis [9]. This evidence concerns the gene KRAS and colorectal carcinoma.